Paul E Firuta - Net Worth and Insider Trading

Paul E Firuta Net Worth

The estimated net worth of Paul E Firuta is at least $399,827 dollars as of 2024-05-05. Paul E Firuta is the Chief Commercial Officer of uniQure NV and owns about 85,251 shares of uniQure NV (QURE) stock worth over $399,827. Details can be seen in Paul E Firuta's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul E Firuta has not made any transactions after 2018-01-03 and currently still holds the listed stock(s).

Transaction Summary of Paul E Firuta

To

Paul E Firuta Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul E Firuta owns 2 companies in total, including Achillion Pharmaceuticals Inc (ACHN) , and uniQure NV (QURE) .

Click here to see the complete history of Paul E Firuta’s form 4 insider trades.

Insider Ownership Summary of Paul E Firuta

Ticker Comapny Transaction Date Type of Owner
ACHN Achillion Pharmaceuticals Inc 2020-01-28 EVP & Chief Commercial Officer
QURE uniQure NV 2018-01-26 Chief Commercial Officer

Paul E Firuta Latest Holdings Summary

Paul E Firuta currently owns a total of 1 stock. Paul E Firuta owns 85,251 shares of uniQure NV (QURE) as of January 3, 2018, with a value of $399,827.

Latest Holdings of Paul E Firuta

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
QURE uniQure NV 2018-01-03 85,251 4.69 399,827

Holding Weightings of Paul E Firuta


Paul E Firuta Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul E Firuta has made a total of 0 transactions in uniQure NV (QURE) over the past 5 years. The most-recent trade in uniQure NV is the sale of 5,864 shares on January 3, 2018, which brought Paul E Firuta around $118,042.

Insider Trading History of Paul E Firuta

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul E Firuta Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul E Firuta Ownership Network

Ownership Network List of Paul E Firuta

No Data

Ownership Network Relation of Paul E Firuta


Paul E Firuta Owned Company Details

What does Achillion Pharmaceuticals Inc do?

Who are the key executives at Achillion Pharmaceuticals Inc?

Paul E Firuta is the EVP & Chief Commercial Officer of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Medical Officer Steven Zelenkofske , General Counsel Martha E Manning , and director & Chief Executive Officer Joseph Truitt .

Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Achillion Pharmaceuticals Inc Insider Transactions

No Available Data

Paul E Firuta Mailing Address

Above is the net worth, insider trading, and ownership report for Paul E Firuta. You might contact Paul E Firuta via mailing address: 550 Hills Drive, Third Floor, Bedminster Nj 07921.

Discussions on Paul E Firuta

No discussions yet.